Sponsor:
National Cancer Institute (NCI)
Code:
NCT03300830
Conditions
Human Immunodeficiency Virus
Castleman's Disease
Kaposi's Sarcoma
Viral-Associated Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Human Immunodeficiency Virus
Castleman's Disease
Kaposi's Sarcoma
Viral-Associated Cancer
Study ID
NCT03300830
Start date
Dec 20, 2017
Status verified date
Aug 20, 2026
Completion date
Jun 25, 2037
Anticipated
Primary completion date
Jun 7, 2037
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
280 participants
Anticipated
Arms
group 1
Primary outcome measure
Central contacts
Locations
National Institutes of Health Clinical Center
Recruiting
Bethesda, Maryland, United States, 20892
Contacts
For more information at the NIH Clinical Center contact National Cancer Institute Referral Office
888-624-1937Sponsor
National Cancer Institute (NCI)
Last update posted
Sep 8, 2026
Last verified
Aug 20, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by National Cancer Institute (NCI) on 2026-09-08.